Related Experiment Video
Updated: Jan 19, 2026

10:13
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.5K
Strength in Numbers: Visualizing CTL-Mediated Killing In Vivo
1Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.
Immunity
|February 18, 2016
Summary
Cytotoxic CD8+ T lymphocytes (CTLs) are not as efficient as previously thought. In vivo imaging revealed each CTL kills only 2-16 targets daily, requiring multiple CTLs to eliminate a single target.
Area of Science:
- Immunology
- Cellular Biology
- In vivo studies
Background:
- Cytotoxic CD8+ T lymphocytes (CTLs) are crucial immune cells traditionally viewed as highly efficient in eliminating target cells.
- Previous assumptions about CTL killing capacity lacked direct in vivo validation.
Purpose of the Study:
- To re-evaluate the killing efficiency of individual CTLs within a living organism.
- To quantify the number of targets eliminated by a single CTL per day.
- To determine the CTL-to-target ratio required for effective target cell clearance.
Main Methods:
- Utilized advanced in vivo imaging techniques to observe CTL-target interactions in real-time.
- Tracked the cytotoxic activity of individual CTLs over a defined period.
- Quantified the number of target cells eliminated by monitored CTLs.
Main Results:
- Contrary to prior beliefs, individual CTLs exhibited a limited killing capacity, eliminating only 2-16 targets per day.
- Effective clearance of target cells required the involvement of multiple CTLs per target.
- The study provides quantitative data on CTL-mediated cytotoxicity in a physiological context.
Conclusions:
- The actual in vivo killing efficiency of CTLs is significantly lower than previously assumed.
- A collaborative effort among multiple CTLs is necessary for robust target cell elimination.
- These findings necessitate a revision of current models of CTL-mediated immune surveillance and response.

